**Abstract**

**Background:** Ketamine, an antagonist on N-methyl-D-aspartate (NMDA) receptor, can produce neurobehavioral changes ranging from mood alterations and psychotic episodes in human to hyperactivity and stereotyped motion in mice. In the study, we tested the pharmacological properties of ketamine on anxiety, locomotion and motor activity.

**Materials and Methods:** Subjects were C57BL/6J mice with age of 6 and 12 weeks at the time of testing. Mice were housed in a temperature- and humidity-controlled vivarium under a 12 h life-dark cycle with ad libitum access to food and water. Sensitivity to acute intoxicating effect was assessed using accelerating rotarod under given doses of ketamine (0, 10, 25, 50 mg/kg, respectively). The elevated plus-mage (EPM) was used to evaluate the anxiety-like behaviors. Open field with videotracking system was adapted to measure the motor responses following acute and chronic ketamine injections.

**Results:** The results demonstrated that the ketamine could dose-dependently potentiate the motor ataxia and significantly increased the open-arm entries at the dose of 25 mg/kg through EPM assessment. Ketamine produced hyperactivity at the age of both 6 and 12 weeks. The adolescent mice significantly increased the total moving distance and speed compared to the adult group.

**Conclusion:** These findings suggest that the effect ketamine is regulated by age and potentiating the sensitivity in the adolescent mice.
